Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles.
Thrombin has been clinically used for topical hemostasis and wound management for more than six decades. The half-life of thrombin in human plasma is shorter than 15s due to close control by inhibitors. In order to stabilize the thrombin, it was bound to maghemite (gamma-Fe(2)O(3)) nanoparticles, as demonstrated in previous work. The aim of the present study was to examine the efficiency of the bound thrombin for wound healing applications compared to the free thrombin. For this purpose incisional wounds on rat skin were treated with a mixture of fibrinogen, CaCl(2) solution and free or bound thrombin. The wounds' edges were then approximated by skin staples. The control incisional wounds were closed with staples only. In the course of 28 days of healing the highest values of skin tensile strength were observed following treatment with the bound thrombin. Significantly lower values of tensile strength were observed following treatment with the free thrombin, and the lowest values were obtained following treatment with staples only. The histological findings correlate with the mechanical strength measurements, which demonstrate the most advanced stages of healing following treatment with the bound thrombin.
Ziv-Polat
Ofra
O
Department of Chemistry, Bar-Ilan University, Ramat-Gan, Israel.
Topaz
Moris
M
Brosh
Tamar
T
Margel
Shlomo
S
D000818:Animals; D002122:Calcium Chloride / Q000494:pharmacology / Q000627:therapeutic use; D062109:Dermatologic Surgical Procedures; D005290:Ferric Compounds / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D005340:Fibrinogen / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D053758:Nanoparticles / Q000737:chemistry / Q000627:therapeutic use; D051381:Rats; D017208:Rats, Wistar; D012867:Skin / Q000473:pathology; D013718:Tensile Strength; D013917:Thrombin / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D014945:Wound Healing / Q000187:drug effects*
D005290:Ferric Compounds; C000499:ferric oxide; D005340:Fibrinogen; D013917:Thrombin; D002122:Calcium Chloride